Search Results - Patrick Altmann

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial by Lisa Voggenberger, Marion Böck, Doris Moser, Gudrun Lorbeer, Patrick Altmann, Fritz Leutmezer, Thomas Berger, Stefan Seidel

    Get full text
    Article


  2. 2

    Cost-effectiveness of the Floodlight MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis by Evelyn Walter, Matthäus Traunfellner, Franz Meyer, Christian Enzinger, Michael Guger, Christian Bsteh, Patrick Altmann, Harald Hegen, Christoph Goger, Veronika Mikl

    Published in Digital Health (2025-01-01)
    Get full text
    Article


  3. 3

    Investigation of serum neurofilament light chain as a biomarker in Fabry disease by Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, Jakob Rath, Patrick Altmann, Thomas Berger, Senta Graf, Gere Sunder-Plassmann, Paulus Stefan Rommer

    Published in Scientific Reports (2024-10-01)
    Get full text
    Article


  4. 4

    Real‐world performance of plasma p‐tau181 in a heterogeneous memory clinic cohort by Tandis Parvizi, Raphael Wurm, Theresa König, Sara Silvaieh, Patrick Altmann, Sigrid Klotz, Guenther Regelsberger, Tatjana Traub‐Weidinger, Ellen Gelpi, Elisabeth Stögmann

    Get full text
    Article


  5. 5

    Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score by Gabriel Bsteh, Harald Hegen, Katharina Riedl, Patrick Altmann, Franziska Di Pauli, Rainer Ehling, Gudrun Zulehner, Paulus Rommer, Fritz Leutmezer, Florian Deisenhammer, Thomas Berger

    Published in Frontiers in Neurology (2022-01-01)
    Get full text
    Article


  6. 6

    Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial by Patrick Altmann, Markus Ponleitner, Tobias Monschein, Nik Krajnc, Gudrun Zulehner, Tobias Zrzavy, Fritz Leutmezer, Paulus Stefan Rommer, Barbara Kornek, Thomas Berger, Gabriel Bsteh

    Published in Digital Health (2022-11-01)
    Get full text
    Article


  7. 7

    Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis by Gabriel Bsteh, Harald Hegen, Patrick Altmann, Klaus Berek, Michael Auer, Anne Zinganell, Franziska Di Pauli, Paulus Rommer, Fritz Leutmezer, Florian Deisenhammer, Thomas Berger

    Get full text
    Article


  8. 8

    Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis by Patrick Altmann, Fritz Leutmezer, Katharina Leithner, Tobias Monschein, Markus Ponleitner, Miranda Stattmann, Paulus Stefan Rommer, Tobias Zrzavy, Gudrun Zulehner, Klaus Berek, Thomas Berger, Gabriel Bsteh

    Published in Frontiers in Neurology (2021-02-01)
    Get full text
    Article


  9. 9

    Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis by Gabriel Bsteh, Harald Hegen, Patrick Altmann, Michael Auer, Klaus Berek, Franziska Di Pauli, Sebastian Wurth, Anne Zinganell, Paulus Rommer, Florian Deisenhammer, Fritz Leutmezer, Thomas Berger

    Get full text
    Article


  10. 10

    Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS by Tobias Zrzavy, Tobias Zrzavy, Kerstin Rieder, Kerstin Rieder, Viktoria Wuketich, Viktoria Wuketich, Renate Thalhammer, Helmuth Haslacher, Patrick Altmann, Patrick Altmann, Barbara Kornek, Barbara Kornek, Nik Krajnc, Nik Krajnc, Tobias Monschein, Tobias Monschein, Christiane Schmied, Christiane Schmied, Karin Zebenholzer, Karin Zebenholzer, Gudrun Zulehner, Gudrun Zulehner, Thomas Berger, Thomas Berger, Paulus Rommer, Paulus Rommer, Fritz Leutmezer, Fritz Leutmezer, Gabriel Bsteh, Gabriel Bsteh

    Published in Frontiers in Neurology (2024-04-01)
    Get full text
    Article


  11. 11

    Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome by Patrick Altmann, Desiree De Simoni, Alexandra Kaider, Birgit Ludwig, Jakob Rath, Fritz Leutmezer, Fritz Zimprich, Romana Hoeftberger, Michael P. Lunn, Amanda Heslegrave, Thomas Berger, Henrik Zetterberg, Paulus Stefan Rommer

    Published in Journal of Neuroinflammation (2020-03-01)
    Get full text
    Article


  12. 12

    Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort studyResearch in context by Harald Hegen, Klaus Berek, Gabriel Bsteh, Michael Auer, Patrick Altmann, Franziska Di Pauli, Astrid Grams, Dejan Milosavljevic, Markus Ponleitner, Paulina Poskaite, Christine Schnabl, Sebastian Wurth, Anne Zinganell, Thomas Berger, Janette Walde, Florian Deisenhammer

    Published in EBioMedicine (2023-05-01)
    Get full text
    Article


  13. 13

    Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold by Gabriel Bsteh, Harald Hegen, Nik Krajnc, Fabian Föttinger, Patrick Altmann, Michael Auer, Klaus Berek, Barbara Kornek, Fritz Leutmezer, Stefan Macher, Tobias Monschein, Markus Ponleitner, Paulus Rommer, Christiane Schmied, Karin Zebenholzer, Gudrun Zulehner, Tobias Zrzavy, Florian Deisenhammer, Franziska Di Pauli, Berthold Pemp, Thomas Berger

    Get full text
    Article


Search Tools: